X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (21555) 21555
Book Review (4965) 4965
Publication (929) 929
Magazine Article (304) 304
Book / eBook (301) 301
Book Chapter (143) 143
Conference Proceeding (60) 60
Newsletter (60) 60
Newspaper Article (33) 33
Dissertation (12) 12
Trade Publication Article (7) 7
Web Resource (6) 6
Paper (4) 4
Patent (4) 4
Data Set (3) 3
Government Document (2) 2
Journal / eJournal (1) 1
Reference (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (16068) 16068
humans (15164) 15164
administration, oral (8109) 8109
female (7848) 7848
male (7490) 7490
warfarin (5148) 5148
anticoagulants - administration & dosage (4989) 4989
aged (4961) 4961
middle aged (4925) 4925
anticoagulants (4725) 4725
anticoagulants - therapeutic use (4599) 4599
adult (3915) 3915
atrial fibrillation (3523) 3523
risk factors (3482) 3482
anticoagulants - adverse effects (3408) 3408
hematology (3253) 3253
peripheral vascular disease (2878) 2878
stroke (2662) 2662
treatment outcome (2655) 2655
oral anticoagulants (2639) 2639
cardiac & cardiovascular systems (2630) 2630
pharmacology & pharmacy (2462) 2462
dabigatran (2406) 2406
abridged index medicus (2316) 2316
aged, 80 and over (2242) 2242
rivaroxaban (2229) 2229
animals (2142) 2142
venous thromboembolism (2122) 2122
thromboembolism (2121) 2121
atrial fibrillation - drug therapy (2110) 2110
risk (2059) 2059
prevention (2031) 2031
therapy (2024) 2024
management (1962) 1962
hemorrhage - chemically induced (1876) 1876
medicine, general & internal (1851) 1851
oral anticoagulation (1851) 1851
dentistry (1813) 1813
atrial-fibrillation (1758) 1758
surgery (1722) 1722
stroke - prevention & control (1708) 1708
international normalized ratio (1700) 1700
thrombosis (1639) 1639
analysis (1559) 1559
atrial fibrillation - complications (1555) 1555
warfarin - therapeutic use (1521) 1521
time factors (1507) 1507
care and treatment (1476) 1476
anticoagulation (1474) 1474
dentistry, oral surgery & medicine (1472) 1472
warfarin - administration & dosage (1455) 1455
medicine & public health (1380) 1380
retrospective studies (1375) 1375
apixaban (1336) 1336
oral anticoagulant-therapy (1203) 1203
warfarin - adverse effects (1202) 1202
drug therapy (1194) 1194
adolescent (1177) 1177
dose-response relationship, drug (1169) 1169
safety (1163) 1163
bleeding (1157) 1157
thromboembolism - prevention & control (1154) 1154
risk assessment (1149) 1149
health aspects (1123) 1123
stroke prevention (1113) 1113
prospective studies (1112) 1112
antithrombotic therapy (1061) 1061
deep-vein thrombosis (1049) 1049
blood coagulation - drug effects (1044) 1044
aspirin (1035) 1035
follow-up studies (1028) 1028
vitamin k - antagonists & inhibitors (1024) 1024
patients (1022) 1022
stroke - etiology (1014) 1014
direct oral anticoagulants (1010) 1010
hemorrhage (979) 979
pharmacokinetics (975) 975
research (966) 966
mortality (952) 952
internal medicine (914) 914
molecular-weight heparin (914) 914
rats (903) 903
anticoagulants - pharmacology (872) 872
cardiology (868) 868
cardiac arrhythmia (854) 854
prothrombin time (847) 847
risk-factors (842) 842
young adult (840) 840
dosage and administration (833) 833
metaanalysis (829) 829
drug interactions (809) 809
drug administration schedule (798) 798
thrombin (789) 789
efficacy (784) 784
clinical trials (747) 747
venous thrombosis (729) 729
medical research (716) 716
oral contraceptives (698) 698
pregnancy (682) 682
randomized controlled trials as topic (680) 680
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
UTL at Downsview - May be requested (158) 158
Dentistry (Harry R Abbott) - Stacks (81) 81
Gerstein Science - Stacks (51) 51
Dentistry (Harry R Abbott) - Withdrawn (50) 50
Dentistry (Harry R Abbott) - May be requested in 6-10 wks (31) 31
Collection Dvlpm't (Acquisitions) - Closed Orders (10) 10
Dentistry (Harry R Abbott) - Circulation Desk (7) 7
Online Resources - Online (7) 7
Collection Dvlpm't (Acquisitions) - Vendor file (6) 6
Dentistry (Harry R Abbott) - May be requested (5) 5
Dentistry (Harry R Abbott) - Searching (3) 3
Lakeridge Health Sciences - Oshawa (3) 3
Robarts - Stacks (3) 3
UofT at Mississauga - Stacks (2) 2
Chemistry (A D Allen) - Stacks (1) 1
Dentistry (Harry R Abbott) - Course Reserves (1) 1
Dentistry (Harry R Abbott) - Mending (1) 1
Dentistry (Harry R Abbott) - Missing (1) 1
Humber River Regional Hospital - Church Stacks (1) 1
New College (Ivey) - Stacks (1) 1
Regis College - Stacks (1) 1
Royal Ontario Museum - Reference (1) 1
Scarborough Hospital - Birchmount (1) 1
Scarborough Hospital - General (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
St. Michael's Hospital - Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
UTL at Downsview - Withdrawn (1) 1
University College (Laidlaw) - May be requested in 6-10 wks (1) 1
UofT at Scarborough - Stacks (1) 1
Women's College Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (20099) 20099
German (674) 674
French (465) 465
Spanish (389) 389
Italian (155) 155
Russian (135) 135
Japanese (88) 88
Portuguese (81) 81
Polish (73) 73
Hungarian (45) 45
Dutch (24) 24
Turkish (24) 24
Czech (20) 20
Danish (20) 20
Chinese (15) 15
Norwegian (15) 15
Swedish (14) 14
Korean (12) 12
Arabic (8) 8
Hebrew (8) 8
Bulgarian (6) 6
Finnish (6) 6
Serbian (6) 6
Slovenian (5) 5
Croatian (4) 4
Romanian (4) 4
Lithuanian (2) 2
Bosnian (1) 1
Estonian (1) 1
Georgian (1) 1
Icelandic (1) 1
Persian (1) 1
Welsh (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American Heart Journal, ISSN 0002-8703, 2016, Volume 182, pp. 28 - 35
Background Non-vitamin K antagonist oral anticoagulants (NOACs, dabigatran, rivaroxaban, apixaban, and edoxaban) have been increasingly used as alternatives to... 
Cardiovascular | INTRAVENOUS THROMBOLYSIS | CARDIAC & CARDIOVASCULAR SYSTEMS | DABIGATRAN ANTICOAGULATION | TISSUE-PLASMINOGEN ACTIVATOR | WARFARIN | ACUTE ISCHEMIC-STROKE | GUIDELINES | INTRACEREBRAL HEMORRHAGE | RISK SCORE | HEALTH-CARE PROFESSIONALS | INTRACRANIAL HEMORRHAGE | United States - epidemiology | Dabigatran - adverse effects | Dabigatran - administration & dosage | Anticoagulants - administration & dosage | Humans | Stroke - diagnosis | Warfarin - adverse effects | Male | Thiazoles - administration & dosage | Antithrombins - administration & dosage | Medication Therapy Management - standards | Warfarin - administration & dosage | Rivaroxaban - administration & dosage | Thiazoles - adverse effects | Pyridones - administration & dosage | Pyridines - adverse effects | Rivaroxaban - adverse effects | Adult | Female | Registries | Stroke - therapy | Pyrazoles - adverse effects | Stroke - prevention & control | Pyridines - administration & dosage | Administration, Oral | Atrial Fibrillation - drug therapy | Atrial Fibrillation - complications | Emergency Treatment - methods | Anticoagulants - adverse effects | Outcome and Process Assessment (Health Care) | Pyrazoles - administration & dosage | Stroke - etiology | Quality Improvement | Antithrombins - adverse effects | Emergency Treatment - mortality | Pyridones - adverse effects | Cohort Studies | Stroke (Disease) | Warfarin | Diet therapy | Stroke patients | Atrial fibrillation | Index Medicus | Abridged Index Medicus
Journal Article
American Journal of Medicine, The, ISSN 0002-9343, 2014, Volume 127, Issue 11, pp. 1075 - 1082.e1
Journal Article
American Heart Journal, ISSN 0002-8703, 2017, Volume 190, pp. 12 - 18
Background Oral anticoagulation prevents ischemic strokes in patients with atrial fibrillation. Early detection of atrial fibrillation and subsequent... 
Cardiovascular | FIBRILLATION | CARDIAC & CARDIOVASCULAR SYSTEMS | STROKE PREVENTION | WARFARIN | CLINICAL-IMPLICATIONS | AMERICAN-COLLEGE | CARDIAC MONITOR | RISK | OPEN-LABEL | TEMPORAL RELATIONSHIP | ISCHEMIC-STROKE | Prospective Studies | Follow-Up Studies | Humans | Male | Thiazoles - administration & dosage | Atrial Fibrillation - physiopathology | Aspirin - administration & dosage | Factor Xa Inhibitors - administration & dosage | Incidence | Time Factors | Female | Stroke - epidemiology | Vitamin K | Heart Rate | Stroke - prevention & control | Pyridines - administration & dosage | Survival Rate - trends | Double-Blind Method | Administration, Oral | Atrial Fibrillation - drug therapy | Risk Factors | Europe - epidemiology | Treatment Outcome | Disease-Free Survival | Stroke - etiology | Atrial Fibrillation - epidemiology | Aged | Fibrinolytic Agents - administration & dosage | Stroke (Disease) | Care and treatment | Anticoagulants (Medicine) | Stroke patients | Atrial fibrillation | Cardiac patients | Implants, Artificial | Prosthesis | Anticoagulants | Therapy | Cardiac arrhythmia | Surgical implants | Aspirin | Stroke | Coagulation | Strokes | Patients | Bleeding | Risk factors | Vitamins | Artifacts | Fibrillation | Ischemia | Defibrillators | Pacemakers | Safety engineering | Electrocardiography | Heart diseases | Index Medicus | Abridged Index Medicus | Trial Design
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 03/2018, Volume 71, Issue 10, pp. 1105 - 1113
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 2014, Volume 111, Issue 5, pp. 781 - 782
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 12/2016, Volume 68, Issue 24, pp. 2597 - 2604
Journal Article
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 07/2018, Volume 72, Issue 1, pp. 27 - 28
In the pivotal phase III RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) trial, which involved 18,113 patients with atrial fibrillation... 
dabigatran | rivaroxaban | apixaban | direct oral anticoagulant | vitamin K antagonist | CARDIAC & CARDIOVASCULAR SYSTEMS | METAANALYSIS | EVENTS | EFFICACY | SAFETY | RISK | ATRIAL-FIBRILLATION | WARFARIN | Myocardial infarction | Anticoagulants | Stroke | Mortality | Cardiovascular disease | Infarction | Health risk assessment
Journal Article
American Heart Journal, ISSN 0002-8703, 2017, Volume 189, pp. 40 - 47